ClinicalTrials.Veeva

Menu

LFR-260 vs Traditional Phoropter in Visual Acuity Testing

E

Evolution Optiks

Status

Completed

Conditions

Astigmatism
Anisometropia
Visual Acuity

Treatments

Device: LFR-260 portable phoropter
Device: Traditional phoropter (SOC)

Study type

Interventional

Funder types

Industry

Identifiers

NCT05259163
LFR-260-2021

Details and patient eligibility

About

The purpose of this study is to establish if LFR-260 (investigational device) is not inferior in effectiveness to a traditional phoropter (control device) when applied in visual acuity test in subjects undergoing a full routine eye examination. LFR-260 proposes to provide information of the visual capabilities of the patient. The test will be provided and supervised by a qualified eye care provider. The informed consent, screening, randomization (into the order of visual test device used), (visual) device testing (to include precision testing, remote and offsite testing) will all occur at a single visit.

Enrollment

112 patients

Sex

All

Ages

12 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. The participant or legal guardian is willing and able to understand, sign and date the Ethics committee approved study specific Informed Consent Form.
  2. The participant is a male or female between the ages of 12 and 65 (inclusive).
  3. The participant has no more than mild to moderate far-sightedness, near-sightedness, astigmatism or anisometropia.
  4. The participant is free of ocular and systemic abnormalities that might affect visual functions.

Exclusion criteria

  1. The participant has diabetes mellitus (Type 1 or 2).
  2. The participant has an autoimmune condition.
  3. The participant is pregnant (self-reported).
  4. The participant has an active corneal or conjunctival infection.
  5. The participant has an active corneal, conjunctival, or intraocular inflammation (i.e. - uveitis).
  6. The participant has diabetic retinopathy.
  7. The participant has glaucoma or ocular hypertension.
  8. The participant has macular degeneration.
  9. The participant has had a previous ocular surgery.
  10. The participant has ocular and systemic diseases or abnormalities that might affect visual functions.
  11. The participant has a history of amblyopia, strabismus, or any other binocular vision abnormality.
  12. The participant has a history of AMD (age macular degeneration).
  13. The participant is a prisoner, a transient or has been treated for alcohol and/or drug abuse in an inpatient substance abuse program within 6 months prior to proposed study enrolment.
  14. The participant will not be able to complete questionnaires.
  15. The participant is currently in an investigational study for a similar purpose.
  16. The participant, in the judgment of the Investigator, may be inappropriate for the intended study procedures.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

112 participants in 2 patient groups

Group 1: LFR-260 first, then traditional phoropter
Experimental group
Description:
The LFR-260 was administered first in this group, followed by the traditional phoropter. The LFR-260 is a portable digital refractor which allows for determination of refractive error as well as for fully remote refractions during eye exams. The traditional phoropter is intended to be used for distance vision testing in any environment.
Treatment:
Device: Traditional phoropter (SOC)
Device: LFR-260 portable phoropter
Group II: Traditional Phoropter first, then LFR-260
Active Comparator group
Description:
The traditional phoropter was administered first in this group, followed by the traditional phoropter. The traditional phoropter is intended to be used for distance vision testing in any environment. The LFR-260 is a portable digital refractor which allows for determination of refractive error as well as for fully remote refractions during eye exams.
Treatment:
Device: Traditional phoropter (SOC)
Device: LFR-260 portable phoropter

Trial documents
1

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems